Metalloproteinases: potential therapeutic targets for rheumatoid arthritis

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 15, Issue 3, 2015, Pages 216-222

  Itoh, Yoshifumi ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

ADAM; ADAMTS; Metalloproteinase; MMP; RA

Indexed keywords

ADAM PROTEIN; AGGRECAN; GAMMA INTERFERON; GELATINASE A; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; MATRIX METALLOPROTEINASE INHIBITOR;

ARTICLE; CELL INFILTRATION; CELL INVASION; CELL MIGRATION; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; TISSUE INJURY; ANIMAL; ANTAGONISTS AND INHIBITORS; ARTHRITIS, RHEUMATOID; DRUG DELIVERY SYSTEM; ENZYMOLOGY; METABOLISM; PROCEDURES; TRENDS;

ANIMALS; ARTHRITIS, RHEUMATOID; DRUG DELIVERY SYSTEMS; HUMANS; MATRIX METALLOPROTEINASE INHIBITORS; METALLOPROTEASES;

EID: 84942089211     PISSN: 18715303     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/1871530315666150316122335     Document Type: Article

References (48)

1. Firestein, G.S. Etiology and Pathogenesis of Rheumatoid Arthritis. In: Kelly's Textbook of Rheumatology, Firestein, G.S.; Budd, R.C.; Gabriel, S.E.; Mcinnes, I.B.; O'Dell, J.R., Eds.; Elsevier Saunders: 2012; Vol. 2, pp 1059-1108.
2. Firestein, G.S. Evolving concepts of rheumatoid arthritis. Nature, 2003, 423(6937), 356-361.
3. Murphy, G.; Nagase, H. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? Nat. Clin. Pract. Rheumatol., 2008, 4(3), 128-135.
4. Edwards, D.R.; Handsley, M.M.; Pennington, C.J. The ADAM metalloproteinases. Mol. Aspects Med., 2008, 29(5), 258-289.
5. Sledge, C.; Reddi, A.; Walsh, D.; Blake, D. Biology of the Normal Joint. In: Kelly's Textbook of Rheumatology, 6th ed.; S, R.; Harris, E. J.; CB, S., Eds. W.B. Saunders Company: Philadelphia, 2001; pp 1-26.
6. Heinegard, D.; Lorenzo, P.; Saxne, T. Matrix Glycoproteins, Proteoglycans, and Cartilage. In: Kelly's Textbook of Rheumatology, 6th ed.; Kelly, W.N.; Ruddy, S.; Harris, E.D.J.; Sledge, C.B., Eds. W.B. Saunders Company: Philadelphia, 2001; pp 41-53
7. Chandler, S.; Cossins, J.; Lury, J.; Wells, G. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem. Biophys. Res. Commun., 1996, 228(2), 421-429.
8. Shipley, J.M.; Wesselschmidt, R.L.; Kobayashi, D.K.; Ley, T.J.; Shapiro, S.D. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc. Natl. Acad. Sci. USA, 1996, 93(9), 3942-3946.
9. Wang, X.; Liang, J.; Koike, T.; Sun, H.; Ichikawa, T.; Kitajima, S.; Morimoto, M.; Shikama, H.; Watanabe, T.; Sasaguri, Y.; Fan, J. Overexpression of human matrix metalloproteinase-12 enhances the development of inflammatory arthritis in transgenic rabbits. Am. J. Pathol., 2004, 165(4), 1375-1383.
10. Koshy, P.J.; Lundy, C.J.; Rowan, A.D.; Porter, S.; Edwards, D. R.; Hogan, A.; Clark, I.M.; Cawston, T.E. The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum., 2002, 46(4), 961-967
11. van Lent, P.L.; Grevers, L.; Blom, A.B.; Sloetjes, A.; Mort, J.S.; Vogl, T.; Nacken, W.; van den Berg, W.B.; Roth, J. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann. Rheum. Dis., 2008, 67(12), 1750-1758
12. van Lent, P.L.; Grevers, L.C.; Blom, A.B.; Arntz, O.J.; van de Loo, F.A.; van der Kraan, P.; Abdollahi-Roodsaz, S.; Srikrishna, G.; Freeze, H.; Sloetjes, A.; Nacken, W.; Vogl, T.; Roth, J.; van den Berg, W.B. Stimulation of chondrocytemediated cartilage destruction by S100A8 in experimental murine arthritis. Arthritis Rheum., 2008, 58(12), 3776-3787
13. Fearon, U.; Mullan, R.; Markham, T.; Connolly, M.; Sullivan, S.; Poole, A. R.; FitzGerald, O.; Bresnihan, B.; Veale, D.J. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures. Arthritis Rheum., 2006, 54(10), 3152-3162.
14. Konttinen, Y.T.; Salo, T.; Hanemaaijer, R.; Valleala, H.; Sorsa, T.; Sutinen, M.; Ceponis, A.; Xu, J.W.; Santavirta, S.; Teronen, O.; Lopez-Otin, C., Collagenase-3 (MMP-13) and its activators in rheumatoid arthritis: localization in the pannus-hard tissue junction and inhibition by alendronate. Matrix Biol., 1999, 18 (4), 401-412.
15. Jungel, A.; Ospelt, C.; Lesch, M.; Thiel, M.; Sunyer, T.; Schorr, O.; Michel, B.A.; Gay, R.E.; Kolling, C.; Flory, C.; Gay, S.; Neidhart, M., Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis. Ann. Rheum. Dis., 2010, 69 (5), 898-902.
16. Konttinen, Y.T.; Ainola, M.; Valleala, H.; Ma, J.; Ida, H.; Mandelin, J.; Kinne, R.W.; Santavirta, S.; Sorsa, T.; Lopez-Otin, C.; Takagi, M. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann. Rheum. Dis., 1999, 58(11), 691-697
17. Pap, T.; Shigeyama, Y.; Kuchen, S.; Fernihough, J. K.; Simmen, B.; Gay, R.E.; Billingham, M.; Gay, S., Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum., 2000, 43(6), 1226-1232
18. Konttinen, Y.T.; Ceponis, A.; Takagi, M.; Ainola, M.; Sorsa, T.; Sutinen, M.; Salo, T.; Ma, J.; Santavirta, S.; Seiki, M. New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above. Matrix Biol., 1998, 17(8-9), 585-601.
19. Miller, M.C.; Manning, H.B.; Jain, A.; Troeberg, L.; Dudhia, J.; Essex, D.; Sandison, A.; Seiki, M.; Nanchahal, J.; Nagase, H.; Itoh, Y., Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis. Arthritis Rheum., 2009, 60 (3), 686-697.
20. Sabeh, F.; Fox, D.; Weiss, S.J. Membrane-type I matrix metalloproteinase-dependent regulation of rheumatoid arthritis synoviocyte function. J. Immunol., 2010, 184(11), 6396-6406.
21. Zhou, Z.; Apte, S.S.; Soininen, R.; Cao, R.; Baaklini, G.Y.; Rauser, R.W.; Wang, J.; Cao, Y.; Tryggvason, K, Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. USA, 2000, 97(8), 4052-4057.
22. Matias-Roman, S.; Galvez, B.G.; Genis, L.; Yanez-Mo, M.; de la Rosa, G.; Sanchez-Mateos, P.; Sanchez-Madrid, F.; Arroyo, A. G., Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium. Blood, 2005, 105(10), 3956-3964
23. Sithu, S.D.; English, W.R.; Olson, P.; Krubasik, D.; Baker, A.H.; Murphy, G.; D'Souza, S.E. Membrane-type 1-matrix metalloproteinase regulates intracellular adhesion molecule-1 (ICAM-1)-mediated monocyte transmigration. J. Biol. Chem., 2007, 282(34), 25010-25019.
24. Gendron, C.; Kashiwagi, M.; Lim, N.H.; Enghild, J.J.; Thogersen, I.B.; Hughes, C.; Caterson, B.; Nagase, H. Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4. J. Biol. Chem., 2007, 282(25), 18294-18306.
25. Stanton, H.; Rogerson, F.M.; East, C.J.; Golub, S.B.; Lawlor, K. E.; Meeker, C.T.; Little, C.B.; Last, K.; Farmer, P.J.; Campbell, I.K.; Fourie, A.M.; Fosang, A.J. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature, 2005, 434(7033), 648-652.
26. Little, C.B.; Meeker, C.T.; Golub, S.B.; Lawlor, K.E.; Farmer, P. J.; Smith, S.M.; Fosang, A.J. Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair. J. Clin. Invest., 2007, 117(6), 1627-1636.
27. Taylor, P.C.; Feldmann, M. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat. Rev. Rheumatol., 2009, 5(10), 578-582
28. Dayer, J.M.; Choy, E. Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor. Rheumatology (Oxford), 2010, 49(1), 15-24.
29. Scheller, J.; Chalaris, A.; Garbers, C.; Rose-John, S. ADAM17: a molecular switch to control inflammation and tissue regeneration. Trends Immunol., 2011, 32(8), 380-387.
30. Mezyk-Kopec, R.; Bzowska, M.; Stalinska, K.; Chelmicki, T.; Podkalicki, M.; Jucha, J.; Kowalczyk, K.; Mak, P.; Bereta, J. Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts. Cytokine, 2009, 46(3), 309-315
31. Arduise, C.; Abache, T.; Li, L.; Billard, M.; Chabanon, A.; Ludwig, A.; Mauduit, P.; Boucheix, C.; Rubinstein, E.; Le Naour, F. Tetraspanins regulate ADAM10-mediated cleavage of TNF-alpha and epidermal growth factor. J. Immunol., 2008, 181(10), 7002-7013.
32. Condon, T.P.; Flournoy, S.; Sawyer, G.J.; Baker, B.F.; Kishimoto, T. K.; Bennett, C.F. ADAM17 but not ADAM10 mediates tumor necrosis factor-alpha and L-selectin shedding from leukocyte membranes. Antisense Nucleic Acid Drug Dev., 2001, 11(2), 107-116.
33. Sakamoto, T.; Seiki, M. Cytoplasmic tail of MT1-MMP regulates macrophage motility independently from its protease activity. Genes Cells, 2009, 14(5), 617-626.
34. Fingleton, B. MMP inhibitor clinical trials-the past, present, and future. Edwards, D.R.; Hoyer-Hansen, G.; Blasi, F.; Sloane, B. F., Eds. Springer: 2008; pp 759-785.
35. Jacobsen, J.A.; Major Jourden, J.L.; Miller, M.T.; Cohen, S.M. To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition. Biochim. Biophys. Acta, 2010, 1803(1), 72-94.
36. Balbin, M.; Fueyo, A.; Tester, A.M.; Pendas, A.M.; Pitiot, A.S.; Astudillo, A.; Overall, C.M.; Shapiro, S.D.; Lopez-Otin, C. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat.Genet., 2003, 35(3), 252-257.
37. Cox, J.H.; Starr, A.E.; Kappelhoff, R.; Yan, R.; Roberts, C.R.; Overall, C.M. Matrix metalloproteinase 8 deficiency in mice exacerbates inflammatory arthritis through delayed neutrophil apoptosis and reduced caspase 11 expression. Arthritis Rheum., 2010, 62(12), 3645-3655.
38. Itoh, T.; Matsuda, H.; Tanioka, M.; Kuwabara, K.; Itohara, S.; Suzuki, R. The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J. Immunol., 2002, 169(5), 2643-2647
39. Mudgett, J.S.; Hutchinson, N.I.; Chartrain, N.A.; Forsyth, A.J.; McDonnell, J.; Singer, II; Bayne, E. K.; Flanagan, J.; Kawka, D.; Shen, C.F.; Stevens, K.; Chen, H.; Trumbauer, M.; Visco, D.M. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum., 1998, 41(1), 110-121
40. Clements, K.M.; Price, J.S.; Chambers, M.G.; Visco, D.M.; Poole, A.R.; Mason, R.M. Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy. Arthritis Rheum., 2003, 48(12), 3452-3463.
41. Marchant, D.J.; Bellac, C.L.; Moraes, T.J.; Wadsworth, S.J.; Dufour, A.; Butler, G.S.; Bilawchuk, L.M.; Hendry, R.G.; Robertson, A.G.; Cheung, C.T.; Ng, J.; Ang, L.; Luo, Z.; Heilbron, K.; Norris, M.J.; Duan, W.; Bucyk, T.; Karpov, A.; Devel, L.; Georgiadis, D.; Hegele, R.G.; Luo, H.; Granville, D.J.; Dive, V.; McManus, B.M.; Overall, C.M. A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity. Nat. Med., 2014, 20(5), 493-502.
42. Zheng, X.; Chung, D.; Takayama, T.K.; Majerus, E.M.; Sadler, J. E.; Fujikawa, K. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J. Biol. Chem., 2001, 276(44), 41059-41063.
43. Levy, G.G.; Nichols, W.C.; Lian, E.C.; Foroud, T.; McClintick, J. N.; McGee, B.M.; Yang, A.Y.; Siemieniak, D.R.; Stark, K.R.; Gruppo, R.; Sarode, R.; Shurin, S.B.; Chandrasekaran, V.; Stabler, S.P.; Sabio, H.; Bouhassira, E.E.; Upshaw, J.D, Jr.; Ginsburg, D.; Tsai, H. M., Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature, 2001, 413(6855), 488-494.
44. Joosten, L.A.; Helsen, M.M.; Saxne, T.; van De Loo, F.A.; Heinegard, D.; van Den Berg, W.B. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collageninduced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J. Immunol., 1999, 163(9), 5049-5055.
45. Chun, T.H.; Sabeh, F.; Ota, I.; Murphy, H.; McDonagh, K.T.; Holmbeck, K.; Birkedal-Hansen, H.; Allen, E.D.; Weiss, S.J. MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J. Cell. Biol., 2004, 167(4), 757-767.
46. Baragi, V.M.; Becher, G.; Bendele, A.M.; Biesinger, R.; Bluhm, H.; Boer, J.; Deng, H.; Dodd, R.; Essers, M.; Feuerstein, T.; Gallagher, B.M., Jr.; Gege, C.; Hochgurtel, M.; Hofmann, M.; Jaworski, A.; Jin, L.; Kiely, A.; Korniski, B.; Kroth, H.; Nix, D.; Nolte, B.; Piecha, D.; Powers, T.S.; Richter, F.; Schneider, M.; Steeneck, C.; Sucholeiki, I.; Taveras, A.; Timmermann, A.; Van Veldhuizen, J.; Weik, J.; Wu, X.; Xia, B. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models. Arthritis Rheum., 2009, 60(7), 2008-2018
47. Monovich, L.G.; Tommasi, R.A.; Fujimoto, R. A.; Blancuzzi, V.; Clark, K.; Cornell, W.D.; Doti, R.; Doughty, J.; Fang, J.; Farley, D.; Fitt, J.; Ganu, V.; Goldberg, R.; Goldstein, R.; Lavoie, S.; Kulathila, R.; Macchia, W.; Parker, D.T.; Melton, R.; O'Byrne, E.; Pastor, G.; Pellas, T.; Quadros, E.; Reel, N.; Roland, D.M.; Sakane, Y.; Singh, H.; Skiles, J.; Somers, J.; Toscano, K.; Wigg, A.; Zhou, S.; Zhu, L.; Shieh, W.-C.; Xue, S.; McQuire, L.W. Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13. J. Med. Chem., 2009, 52(11), 3523-3538.
48. Devy, L.; Huang, L.; Naa, L.; Yanamandra, N.; Pieters, H.; Frans, N.; Chang, E.; Tao, Q.; Vanhove, M.; Lejeune, A.; van Gool, R.; Sexton, D.J.; Kuang, G.; Rank, D.; Hogan, S.; Pazmany, C.; Ma, Y. L.; Schoonbroodt, S.; Nixon, A.E.; Ladner, R.C.; Hoet, R.; Henderikx, P.; Tenhoor, C.; Rabbani, S.A.; Valentino, M.L.; Wood, C.R.; Dransfield, D.T. Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. Cancer Res., 2009, 69(4), 1517-1526.